Pirin: A Potential Novel Therapeutic Target for Castration-Resistant Prostate Cancer Regulated by miR-455-5p

Molecular Oncology - Netherlands
doi 10.1002/1878-0261.12405
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

LINE-1 as a Therapeutic Target for Castration-Resistant Prostate Cancer

Frontiers in Bioscience - Landmark
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2018English

Emerging Role of Glucocorticoid Receptor in Castration Resistant Prostate Cancer: A Potential Therapeutic Target

Journal of Cancer
Oncology
2020English

MiR-30a: A Novel Biomarker and Potential Therapeutic Target for Cancer

Journal of Oncology
Oncology
2018English

ZBTB46, SPDEF, and ETV6: Novel Potential Biomarkers and Therapeutic Targets in Castration-Resistant Prostate Cancer

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2019English

Androgen-Regulated miR-32 Targets BTG2 and Is Overexpressed in Castration-Resistant Prostate Cancer

Oncogene
Cancer ResearchGeneticsMolecular Biology
2012English

Ailanthone: A New Potential Drug for Castration-Resistant Prostate Cancer

Chinese Journal of Cancer
2017English

STAT3 and STAT5A Are Potential Therapeutic Targets in Castration-Resistant Prostate Cancer

Oncotarget
Oncology
2017English

Increased Androgen Receptor Transcription: A Cause of Castration-Resistant Prostate Cancer and a Possible Therapeutic Target

Journal of Molecular Endocrinology
EndocrinologyMolecular Biology
2011English

Targeting TCTP as a New Therapeutic Strategy in Castration-Resistant Prostate Cancer

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy